Selected research
Industry Research
Amiodarone Industry Research Report 2026
Market perspective
The global Amiodarone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Amiodarone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Amiodarone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Amiodarone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Amiodarone include Shanghai Pharmaceuticals, Sanofi, Mylan Pharmaceuticals, North China Pharmaceutical Company, Harbin Pharmaceutical Group, Wyeth Pharmaceuticals (Pfizer), Sawai Pharmaceutical, Roemmers and Cipla Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Amiodarone market in terms of revenue (US$ million) and, where applicable, sales volume (m units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/m units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Amiodarone Market by Company
Shanghai Pharmaceuticals
Sanofi
Mylan Pharmaceuticals
North China Pharmaceutical Company
Harbin Pharmaceutical Group
Wyeth Pharmaceuticals (Pfizer)
Sawai Pharmaceutical
Roemmers
Cipla Pharmaceutical
Arrow Pharma Pty Ltd
Amiodarone Segment by Type
Injection Amiodarone
Tablet Amiodarone
Capsule Amiodarone
Amiodarone Segment by Application
Ventricular Tachycardia
Atrial Fibrillation
Cardiac Arrest
Others
Amiodarone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amiodarone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amiodarone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amiodarone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Amiodarone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Amiodarone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Amiodarone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection Amiodarone
- Tablet Amiodarone
- Capsule Amiodarone
Applications
- Ventricular Tachycardia
- Atrial Fibrillation
- Cardiac Arrest
- Others
Companies covered
- Shanghai Pharmaceuticals
- Sanofi
- Mylan Pharmaceuticals
- North China Pharmaceutical Company
- Harbin Pharmaceutical Group
- Wyeth Pharmaceuticals (Pfizer)
- Sawai Pharmaceutical
- Roemmers
- Cipla Pharmaceutical
- Arrow Pharma Pty Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Amiodarone Market Size (2021-2032)
- 2.2.2 Global Amiodarone Sales (2021-2032)
- 2.2.3 Global Amiodarone Market Average Price (2021-2032)
- 2.3 Amiodarone by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injection Amiodarone
- 2.3.3 Tablet Amiodarone
- 2.3.4 Capsule Amiodarone
- 2.4 Amiodarone by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Ventricular Tachycardia
- 2.4.3 Atrial Fibrillation
- 2.4.4 Cardiac Arrest
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Amiodarone Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Amiodarone Sales (m units) of Manufacturers (2021-2026)
- 3.3 Global Amiodarone Revenue of Manufacturers (2021-2026)
- 3.4 Global Amiodarone Average Price by Manufacturers (2021-2026)
- 3.5 Global Amiodarone Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Amiodarone, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Amiodarone, Product Type & Application
- 3.8 Global Manufacturers of Amiodarone, Established Date
- 3.9 Global Amiodarone Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Shanghai Pharmaceuticals
- 4.1.1 Shanghai Pharmaceuticals Company Information
- 4.1.2 Shanghai Pharmaceuticals Business Overview
- 4.1.3 Shanghai Pharmaceuticals Amiodarone Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Shanghai Pharmaceuticals Amiodarone Product Portfolio
- 4.1.5 Shanghai Pharmaceuticals Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Amiodarone Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Amiodarone Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Mylan Pharmaceuticals
- 4.3.1 Mylan Pharmaceuticals Company Information
- 4.3.2 Mylan Pharmaceuticals Business Overview
- 4.3.3 Mylan Pharmaceuticals Amiodarone Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mylan Pharmaceuticals Amiodarone Product Portfolio
- 4.3.5 Mylan Pharmaceuticals Recent Developments
- 4.4 North China Pharmaceutical Company
- 4.4.1 North China Pharmaceutical Company Company Information
- 4.4.2 North China Pharmaceutical Company Business Overview
- 4.4.3 North China Pharmaceutical Company Amiodarone Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 North China Pharmaceutical Company Amiodarone Product Portfolio
- 4.4.5 North China Pharmaceutical Company Recent Developments
- 4.5 Harbin Pharmaceutical Group
- 4.5.1 Harbin Pharmaceutical Group Company Information
- 4.5.2 Harbin Pharmaceutical Group Business Overview
- 4.5.3 Harbin Pharmaceutical Group Amiodarone Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Harbin Pharmaceutical Group Amiodarone Product Portfolio
- 4.5.5 Harbin Pharmaceutical Group Recent Developments
- 4.6 Wyeth Pharmaceuticals (Pfizer)
- 4.6.1 Wyeth Pharmaceuticals (Pfizer) Company Information
- 4.6.2 Wyeth Pharmaceuticals (Pfizer) Business Overview
- 4.6.3 Wyeth Pharmaceuticals (Pfizer) Amiodarone Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Wyeth Pharmaceuticals (Pfizer) Amiodarone Product Portfolio
- 4.6.5 Wyeth Pharmaceuticals (Pfizer) Recent Developments
- 4.7 Sawai Pharmaceutical
- 4.7.1 Sawai Pharmaceutical Company Information
- 4.7.2 Sawai Pharmaceutical Business Overview
- 4.7.3 Sawai Pharmaceutical Amiodarone Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sawai Pharmaceutical Amiodarone Product Portfolio
- 4.7.5 Sawai Pharmaceutical Recent Developments
- 4.8 Roemmers
- 4.8.1 Roemmers Company Information
- 4.8.2 Roemmers Business Overview
- 4.8.3 Roemmers Amiodarone Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Roemmers Amiodarone Product Portfolio
- 4.8.5 Roemmers Recent Developments
- 4.9 Cipla Pharmaceutical
- 4.9.1 Cipla Pharmaceutical Company Information
- 4.9.2 Cipla Pharmaceutical Business Overview
- 4.9.3 Cipla Pharmaceutical Amiodarone Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Cipla Pharmaceutical Amiodarone Product Portfolio
- 4.9.5 Cipla Pharmaceutical Recent Developments
- 4.10 Arrow Pharma Pty Ltd
- 4.10.1 Arrow Pharma Pty Ltd Company Information
- 4.10.2 Arrow Pharma Pty Ltd Business Overview
- 4.10.3 Arrow Pharma Pty Ltd Amiodarone Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Arrow Pharma Pty Ltd Amiodarone Product Portfolio
- 4.10.5 Arrow Pharma Pty Ltd Recent Developments
5 Global Amiodarone Market Scenario by Region
- 5.1 Global Amiodarone Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Amiodarone Sales by Region: 2021-2032
- 5.2.1 Global Amiodarone Sales by Region: 2021-2026
- 5.2.2 Global Amiodarone Sales by Region: 2027-2032
- 5.3 Global Amiodarone Revenue by Region: 2021-2032
- 5.3.1 Global Amiodarone Revenue by Region: 2021-2026
- 5.3.2 Global Amiodarone Revenue by Region: 2027-2032
- 5.4 North America Amiodarone Market Facts & Figures by Country
- 5.4.1 North America Amiodarone Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Amiodarone Sales by Country (2021-2032)
- 5.4.3 North America Amiodarone Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Amiodarone Market Facts & Figures by Country
- 5.5.1 Europe Amiodarone Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Amiodarone Sales by Country (2021-2032)
- 5.5.3 Europe Amiodarone Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Amiodarone Market Facts & Figures by Country
- 5.6.1 Asia Pacific Amiodarone Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Amiodarone Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Amiodarone Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Amiodarone Market Facts & Figures by Country
- 5.7.1 South America Amiodarone Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Amiodarone Sales by Country (2021-2032)
- 5.7.3 South America Amiodarone Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Amiodarone Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Amiodarone Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Amiodarone Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Amiodarone Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Amiodarone Sales by Type (2021-2032)
- 6.1.1 Global Amiodarone Sales by Type (2021-2032) & (m units)
- 6.1.2 Global Amiodarone Sales Market Share by Type (2021-2032)
- 6.2 Global Amiodarone Revenue by Type (2021-2032)
- 6.2.1 Global Amiodarone Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Amiodarone Revenue Market Share by Type (2021-2032)
- 6.3 Global Amiodarone Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Amiodarone Sales by Application (2021-2032)
- 7.1.1 Global Amiodarone Sales by Application (2021-2032) & (m units)
- 7.1.2 Global Amiodarone Sales Market Share by Application (2021-2032)
- 7.2 Global Amiodarone Revenue by Application (2021-2032)
- 7.2.1 Global Amiodarone Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Amiodarone Revenue Market Share by Application (2021-2032)
- 7.3 Global Amiodarone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Amiodarone Value Chain Analysis
- 8.1.1 Amiodarone Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Amiodarone Production Mode & Process
- 8.2 Amiodarone Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Amiodarone Distributors
- 8.2.3 Amiodarone Customers
9 Global Amiodarone Analyzing Market Dynamics
- 9.1 Amiodarone Industry Trends
- 9.2 Amiodarone Industry Drivers
- 9.3 Amiodarone Industry Opportunities and Challenges
- 9.4 Amiodarone Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst